Silvia Burlina

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes

Giovanni Sartore, Nino Cristiano Chilelli, Silvia Burlina et al. · Acta Diabetologica · 2013 · 127 citations

Diabetic Retinopathy, Diabetes Management, Diabetes Epidemiology +9

The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)

Giovanni Sartore, Nino Cristiano Chilelli, Silvia Burlina et al. · Acta Diabetologica · 2012 · 86 citations

Metabolic Syndrome, Type 1, Diabetes Management +5

The effects of psyllium on lipoproteins in type II diabetic patients

Giovanni Sartore, R. Reitano, A. Barison et al. · European Journal of Clinical Nutrition · 2009 · 45 citations

Obesity, Metabolic Syndrome, Cardiovascular Disease +11

Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population

Nino Cristiano Chilelli, Chiara Cosma, Eugenio Ragazzi et al. · Acta Diabetologica · 2014 · 18 citations

Real-world Caucasian Population, Metabolic Syndrome, Diabetes Management +9